Genetic and Histopathologic Characteristics of Interstitial Cystitis
NCT ID: NCT03523559
Last Updated: 2024-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
14 participants
OBSERVATIONAL
2018-03-31
2024-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study)
NCT02331472
The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome
NCT01985880
The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.
NCT01813565
Supervised Exercise as a Therapeutic Strategy for Interstitial Cystitis/Bladder Pain Syndrome
NCT05699551
Emotional Urinary Tract Infection
NCT07191041
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interstitial Cystitis
bladder tissue of Interstitial Cystitis and normal bladder tissue
Obtain the bladder tissue of Interstitial Cystitis and normal during the operation
normal
bladder tissue of Interstitial Cystitis and normal bladder tissue
Obtain the bladder tissue of Interstitial Cystitis and normal during the operation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bladder tissue of Interstitial Cystitis and normal bladder tissue
Obtain the bladder tissue of Interstitial Cystitis and normal during the operation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with Hunner lesion in Interstitial cystitis and who is scheduled to undergo transurethral resection
* Patients diagnosed with Bladder cancer and who is scheduled to undergo cystectomy
Exclusion Criteria
* A person whose area of bladder cancer is larger than that of the normal area
* A person who is going to have a cystectomy after chemotherapy on bladder cancer
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
KYU-SUNG LEE
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Medical Center, Sungkyunkwan University School of Medicine
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-03-025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.